钠-葡萄糖协同转运蛋白2抑制剂在预防导管消融术后房颤复发中的疗效。 - Suppr

Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing atrial fibrillation recurrence after catheter ablation.

作者信息

Stachteas Panagiotis, Karakasis Paschalis, Karagiannidis Efstratios, Patoulias Dimitrios, Athanasiadou Polyxeni, Nasoufidou Athina, Papadopoulos Christodoulos, Kassimis George, Fragakis Nikolaos

机构信息

Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Greece.

出版信息

Hellenic J Cardiol. 2024 Sep-Oct;79:86-87. doi: 10.1016/j.hjc.2024.03.008. Epub 2024 Mar 12.

DOI:10.1016/j.hjc.2024.03.008

PMID:38484841

Abstract

摘要

相似文献

Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing atrial fibrillation recurrence after catheter ablation.钠-葡萄糖协同转运蛋白2抑制剂在预防导管消融术后房颤复发中的疗效。

Hellenic J Cardiol. 2024 Sep-Oct;79:86-87. doi: 10.1016/j.hjc.2024.03.008. Epub 2024 Mar 12.

SGLT2 Inhibitors and Catheter Ablation for Atrial Fibrillation: Go With the Flow-zin?钠-葡萄糖协同转运蛋白2抑制剂与心房颤动的导管消融治疗：顺应潮流？

JACC Clin Electrophysiol. 2023 Oct;9(10):2119-2121. doi: 10.1016/j.jacep.2023.06.017. Epub 2023 Sep 6.

Detailed mechanism of SGLT2 inhibitor therapy on preventing arrhythmia recurrence after atrial fibrillation ablation.SGLT2抑制剂治疗预防心房颤动消融术后心律失常复发的详细机制。

J Cardiovasc Electrophysiol. 2024 Oct;35(10):2090. doi: 10.1111/jce.16387. Epub 2024 Jul 29.

Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes.SGLT2 抑制剂对 2 型糖尿病患者导管消融术后 AF 复发的影响。

JACC Clin Electrophysiol. 2023 Oct;9(10):2109-2118. doi: 10.1016/j.jacep.2023.06.008. Epub 2023 Aug 9.

Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study.达格列净改善房颤消融术后心律失常相关结局的疗效：一项回顾性单中心研究。

Clin Res Cardiol. 2024 Jun;113(6):924-932. doi: 10.1007/s00392-024-02389-3. Epub 2024 Feb 15.

Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity-Score Matching Study and Meta-Analysis.钠-葡萄糖共转运蛋白 2 抑制剂对糖尿病患者导管消融术后房颤复发的影响：一项倾向评分匹配研究和荟萃分析。

J Am Heart Assoc. 2023 Dec 19;12(24):e031269. doi: 10.1161/JAHA.123.031269. Epub 2023 Dec 12.

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation.钠-葡萄糖共转运蛋白 2 抑制剂对导管消融治疗心房颤动后结局的影响。

JACC Clin Electrophysiol. 2022 Nov;8(11):1393-1404. doi: 10.1016/j.jacep.2022.08.004. Epub 2022 Oct 26.

Does Additional Electrogram-Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study.线性消融术后额外的电信号引导消融能否降低长期持续性心房颤动导管消融后的复发率？一项前瞻性随机研究。

J Am Heart Assoc. 2017 Feb 7;6(2):e004811. doi: 10.1161/JAHA.116.004811.

Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.BEYOND 试验方案：钠-葡萄糖共转运蛋白-2（SGLT-2）抑制剂在糖尿病患者节律控制心房颤动中的临床获益。

PLoS One. 2023 Jan 18;18(1):e0280359. doi: 10.1371/journal.pone.0280359. eCollection 2023.

SGLT2 Inhibitors After Catheter Ablation for Atrial Fibrillation in Diabetes: Is Heart Failure a Moderator?糖尿病患者房颤导管消融术后的SGLT2抑制剂：心力衰竭是一个调节因素吗？

JACC Clin Electrophysiol. 2023 Dec;9(12):2664. doi: 10.1016/j.jacep.2023.08.039.

引用本文的文献

Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications.意义未明的克隆性造血与心房颤动：对病理生理学及临床意义的见解

Int J Mol Sci. 2025 Mar 18;26(6):2739. doi: 10.3390/ijms26062739.

Sodium-glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂与转甲状腺素蛋白淀粉样心肌病的预后：系统评价与荟萃分析

Eur J Clin Invest. 2025 Jun;55(6):e14392. doi: 10.1111/eci.14392. Epub 2025 Jan 27.

Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets.心房颤动中的心房纤维化：机制洞察、诊断挑战及新兴治疗靶点

Int J Mol Sci. 2024 Dec 30;26(1):209. doi: 10.3390/ijms26010209.

The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review.钠-葡萄糖协同转运蛋白2抑制剂在心房颤动中的作用：综述

J Clin Med. 2024 Sep 12;13(18):5408. doi: 10.3390/jcm13185408.

Early versus Late Radiofrequency Catheter Ablation in Atrial Fibrillation: Timing Matters.心房颤动早期与晚期射频导管消融：时机很重要。

J Clin Med. 2024 Aug 8;13(16):4643. doi: 10.3390/jcm13164643.

Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis.胰高血糖素样肽-1 受体激动剂对导管消融后心房颤动复发的影响：系统评价和荟萃分析。

Adv Ther. 2024 Oct;41(10):3749-3756. doi: 10.1007/s12325-024-02959-x. Epub 2024 Aug 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing atrial fibrillation recurrence after catheter ablation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献